Research Information System
Bratislava Medical Journal, vol.126, no.6, pp.1136-1142, 2025 (SCI-Expanded)
Objective: This study aims to assess depressive and anxiety symptoms as well as somatosensory amplification tendency in patients with polycystic ovary syndrome (PCOS) and to analyze their scale scores. Material and methods: This study included 140 women aged 18–45, comprising 70 diagnosed with PCOS and 70 healthy controls. Patients with PCOS were assessed for using the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), The Somatosensory Amplification Scale (SSAS), and Health Anxiety Inventory (HAI) questionnaires. Results: In comparison to the control group, the PCOS group exhibited substantially higher mean scores on the Somatosensory Amplification Scale (SSAS), Health Anxiety Inventory (HAI), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI) (p < 0.001). The PCOS patients in our research had mean BAI scores of 19.6, mean BDI scores of 14.7, mean SSAS scores of 32.6, and mean HAI scores of 18.7. Conclusions: In our study, PCOS patients scored higher on measures of somatosensory amplification, depressive, and anxiety symptoms than the control group. We wish to underline the need for timely psychological assessment and support for individuals diagnosed with PCOS. Consequently, we believe that early identification and management of psychological distress will reduce the need for recurrent medical care.